While 93 percent of U.S. pediatricians surveyed were aware of the national guidelines on peanut allergy prevention in infants, only 30 percent were fully implementing the recommended practices and 64 percent reported partial implementation, according to the study published in JAMA Network Open.
Researchers at the Icahn School of Medicine report that roflumilast cream (ARQ-151), which contains a highly potent, selective phosphodiesterase-4 (PDE4) inhibitor demonstrated significant improvements in patients with psoriasis signs and symptoms in as early as two weeks. The phase 2b trial results showed that when patients with plaque psoriasis applied topical roflumilast once-daily they reported clear skin as well as improvement in itch and burden of disease.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19, was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published today in The New England Journal of Medicine. The ongoing Phase 1 trial is supported by the National Institute of Allergy and Infectious Diseases (NIAID). The experimental vaccine is being co-developed by researchers at NIAID and at Moderna, Inc.
Annals of Family Medicine is a peer-reviewed, indexed research journal that provides a cross-disciplinary forum for new, evidence-based information affecting the primary care disciplines.
Researchers have showed that HLA-G gene regulates male-to-female ratio at birth. The study strengthens earlier findings of the vulnerability of male fetuses to preeclampsia.
Researchers developed a new dynamic light scattering method to determine the sizes of circulating immune complexes in blood serum. The results of the study were published in the first quartile Biology Journal, MDPI Publishing House. Scientists mentioned, that this method is fast, contactless, safe and cheap.
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen. Researchers from the Wyss Institute and Harvard SEAS have harnessed this innate ability to create a technology that uses red blood cells to initiate a strong immune response against an antigen without the need for a foreign adjuvant, setting the stage for safer, more effective vaccines.
Breast Cancer patients are 60 percent more likely to die of cancer after surviving a heart attack, a new study finds.
Scientists say they are a step closer to developing a drug to kill the trypanosome parasite that causes human African trypanosomiasis, otherwise known as sleeping sickness, paving the way for a potential cure.
Human papilloma viruses (HPVs) - a common group of viruses known to cause cervical cancers - may also have a causal role in prostate cancer, according to a literature review published in the open access journal Infectious Agents and Cancer, supporting the case for universal HPV vaccination.